What is the average amount of daily hair loss? For most healthy adults, losing between 50 and 100 hairs per day is entirely normal and a natural part of the hair growth cycle. With up to 120,000 follicles on the scalp cycling independently, everyday shedding rarely causes visible thinning. However, understanding when hair loss exceeds this range — and what might be driving it — is important for identifying conditions that may need medical attention. This article explains normal shedding, common causes of increased hair loss, when to see your GP, and the treatment options available on the NHS.

How Much Hair Loss Per Day Is Considered Normal?

Losing 50 to 100 hairs per day is considered entirely normal and is a natural part of the hair growth cycle, rarely resulting in visible thinning.

Most people lose between 50 and 100 hairs per day, and this is considered entirely within the normal range. This level of shedding is a natural part of the hair growth cycle and does not typically result in visible thinning or bald patches.

The human scalp contains approximately 80,000 to 120,000 hair follicles, each cycling independently through phases of growth, transition, and rest. Because only a small proportion of follicles shed at any one time, everyday hair loss is rarely noticeable. You may observe loose hairs on your pillow, in the shower drain, or on a hairbrush — this is normal and expected.

The number of hairs shed can vary from person to person depending on factors such as hair length, thickness, and washing frequency. People who wash their hair less frequently may notice more hairs falling at once during washing, simply because shed hairs have accumulated between washes. This does not mean more hair is being lost overall — the daily average remains broadly consistent across healthy adults.

What Causes Everyday Hair Shedding?

Everyday shedding is caused by the natural hair growth cycle, in which hairs in the telogen (resting) phase fall out before new growth begins — accounting for the 50–100 hairs lost daily.

Everyday hair shedding is driven by the natural hair growth cycle, which consists of three main phases:

• Anagen (growth phase): Lasting two to seven years, during which the hair actively grows from the follicle.

• Catagen (transition phase): A short period of two to three weeks where growth slows and the follicle shrinks.

• Telogen (resting phase): Lasting around three months, after which the hair is shed and a new hair begins to grow in its place.

At any given time, approximately 85–90% of scalp hairs are in the anagen phase, while around 10–15% are in the telogen phase and preparing to shed. This means that on any given day, a proportion of hairs will naturally fall out as part of this cycle — this is what accounts for the 50–100 hairs lost daily.

Hormonal fluctuations, seasonal changes, and stress can subtly influence how many hairs enter the telogen phase simultaneously. Some research suggests that hair shedding may be marginally higher in autumn, though this seasonal variation is modest and its clinical significance is limited. Understanding that shedding is a physiological process — not a sign of damage — can help reduce unnecessary anxiety about normal hair loss.

When Does Hair Loss Become a Medical Concern?

Hair loss becomes a medical concern when shedding significantly exceeds the normal range, visible thinning or bald patches develop, or loss occurs suddenly without an obvious cause.

Hair loss becomes a potential medical concern when shedding significantly exceeds the normal daily range, when visible thinning or bald patches develop, or when hair loss occurs suddenly and without an obvious explanation. Losing clumps of hair, noticing a widening parting, or finding large amounts of hair on the pillow or in the shower over a sustained period are all signs that warrant further attention.

It is important to distinguish between hair shedding (telogen effluvium) — a temporary increase in daily hair loss often triggered by a specific event — and hair loss (alopecia) — a longer-term reduction in hair density that may have a structural or autoimmune cause. Both can present with increased daily shedding, but their underlying mechanisms and management differ considerably.

A simple supportive assessment sometimes used in clinical practice is the pull test: gently pulling a small bunch of around 40–60 hairs between your fingers. Losing more than six hairs in a single pull may suggest increased shedding and is worth discussing with a healthcare professional. This test is operator-dependent and should be interpreted alongside a full clinical assessment rather than in isolation.

Urgent red flags requiring prompt medical review include:

• Scalp pain, tenderness, perifollicular redness or scaling, pustules, or rapid progression of hair loss — these may indicate scarring alopecia, which can cause permanent follicle damage if not treated promptly, and warrants expedited dermatology assessment.

• In children, patchy hair loss accompanied by scalp scaling, broken hairs, or lymphadenopathy may suggest tinea capitis (a fungal scalp infection), which requires prompt assessment and systemic antifungal treatment.

Conditions That Can Increase Daily Hair Shedding

Telogen effluvium, thyroid disorders, iron deficiency, androgenetic alopecia, and alopecia areata are among the most common conditions that cause daily shedding to exceed the normal range.

A number of medical conditions and lifestyle factors can cause daily hair shedding to exceed the normal range. Some of the most commonly identified causes include:

• Telogen effluvium: A temporary condition in which a large number of hairs simultaneously enter the resting phase, often triggered by physical or emotional stress, illness, surgery, rapid weight loss, or childbirth. Hair loss typically begins two to three months after the triggering event.

• Thyroid disorders: Both hypothyroidism and hyperthyroidism can disrupt the hair growth cycle, leading to diffuse shedding. Thyroid function tests are considered where there is clinical suspicion or unexplained diffuse hair loss, in line with PCDS and NICE CKS guidance.

• Iron deficiency: Low ferritin levels are associated with increased hair shedding, particularly in women of reproductive age. A full blood count and serum ferritin test are standard first-line investigations where deficiency is suspected; confirmed deficiency should be investigated and treated.

• Androgenetic alopecia: The most common form of patterned hair loss, affecting both men and women. It is driven by sensitivity to dihydrotestosterone (DHT) and results in progressive follicle miniaturisation.

• Alopecia areata: An autoimmune condition causing patchy hair loss, which can occasionally progress to total scalp or body hair loss.

• Nutritional deficiencies: Low levels of certain nutrients, including vitamin D and zinc, have been associated with hair shedding in some studies, though evidence remains limited. Supplementation should only be considered where a deficiency has been confirmed by testing; routine testing is not recommended without a clinical indication. If you are taking biotin (vitamin B7) supplements, it is important to inform your doctor before blood tests, as the MHRA has advised that biotin can interfere with a range of laboratory test results and may cause misleading findings.

Certain medicines — including anticoagulants, retinoids, and some antidepressants — are also recognised causes of increased hair shedding. If you are concerned that a prescribed medicine may be contributing to hair loss, speak to your GP or pharmacist before making any changes; do not stop prescribed medication without medical advice.

When to See a GP About Hair Loss

See your GP if you notice sudden or patchy hair loss, visible scalp thinning, scalp symptoms such as redness or scaling, or hair loss accompanied by systemic symptoms such as fatigue or weight changes.

You should consider making an appointment with your GP if you notice any of the following:

• Sudden or rapid hair loss over a short period, particularly if it occurs in patches

• Visible thinning of the scalp or a noticeably widening parting

• Hair loss accompanied by other symptoms, such as fatigue, weight changes, skin changes, or irregular periods, which may suggest an underlying systemic condition

• Scalp symptoms such as redness, scaling, itching, soreness, or pustules, which could indicate a dermatological cause including scarring alopecia — seek prompt review

• Hair loss in children, which always warrants prompt medical review; patchy loss with scalp scaling or lymphadenopathy should be assessed urgently for tinea capitis

Your GP will typically take a detailed medical and medication history, examine the pattern and distribution of hair loss, and arrange relevant blood tests where clinically indicated. First-line investigations commonly include a full blood count, thyroid function tests, and serum ferritin. Further tests — such as vitamin D or other markers — may be considered if there is a specific clinical indication or risk of deficiency, but are not routinely recommended for all patients presenting with hair loss.

Where the diagnosis is unclear, hair loss is progressing rapidly, or there are features suggesting scarring alopecia or another specialist condition, referral to a NHS dermatologist is appropriate. If you choose to consult a trichologist privately, please be aware that trichology is not a statutorily regulated healthcare profession in the UK; any advice received should be discussed with your GP or a qualified medical specialist. It is important not to delay seeking advice if hair loss is causing distress — early investigation can identify treatable causes and prevent unnecessary progression.

Treatment and Support Options Available on the NHS

NHS treatment depends on the underlying cause; options include addressing reversible triggers, topical minoxidil for androgenetic alopecia, and corticosteroids or JAK inhibitors for alopecia areata.

Treatment for hair loss on the NHS depends on the underlying cause. Where a reversible trigger is identified — such as iron deficiency, thyroid dysfunction, or another treatable condition — addressing the root cause often leads to natural hair regrowth over several months. Patients should be counselled that regrowth following telogen effluvium, for example, can take six to twelve months and requires patience.

For androgenetic alopecia, topical minoxidil (available as a solution or foam) is the most widely used treatment. In the UK, topical minoxidil products are available over the counter from pharmacies without a prescription and are not routinely prescribed on the NHS for pattern hair loss. Its precise mechanism is not fully understood, but it is thought to prolong the anagen (growth) phase and increase follicle size. Oral minoxidil is used in some specialist settings but is off-label and not routinely available on the NHS.

Finasteride 1 mg is licensed in the UK for male pattern hair loss. It works by inhibiting 5-alpha reductase, thereby reducing levels of dihydrotestosterone (DHT). It is most commonly obtained via private prescription rather than NHS prescription. Important safety information: finasteride can cause sexual side effects (including reduced libido and erectile dysfunction) and psychiatric effects (including depression); patients should discuss these risks with their prescriber before starting treatment. Finasteride is contraindicated in women who are pregnant or may become pregnant due to the risk of harm to a male foetus. Women with androgenetic alopecia may be offered anti-androgen therapies in specialist settings; these are not routinely available on the NHS. For full prescribing information, refer to the Summary of Product Characteristics (SmPC) available via the electronic Medicines Compendium (emc).

For alopecia areata, treatment options available through the NHS include:

• Topical or intralesional corticosteroids to suppress the autoimmune response

• Contact immunotherapy (diphencyprone), used in specialist dermatology centres for extensive cases; this treatment is off-label and only available in specialist settings

• JAK inhibitors: Baricitinib (Olumiant) is approved by the MHRA and has been evaluated by NICE for severe alopecia areata in adults meeting specific eligibility criteria. Ritlecitinib (Litfulo) is licensed by the MHRA for severe alopecia areata in adults and adolescents aged 12 years and over. Commissioning and availability on the NHS are subject to current NICE Technology Appraisal guidance; patients should discuss eligibility with their specialist. Refer to the relevant SmPCs and NICE Technology Appraisals for full prescribing, safety, and funding information.

If you experience any suspected side effects from medicines used to treat hair loss, please report them via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk or via the Yellow Card app.

Beyond medical treatment, the NHS recognises the psychological impact of hair loss. Patients experiencing significant distress may benefit from referral to psychological support services. Organisations such as Alopecia UK also provide peer support and practical guidance. Wigs are available on the NHS for certain conditions, including alopecia areata, and can be accessed via a GP or hospital prescription.

Frequently Asked Questions